ArticleJournal of assisted reproduction and genetics2026
Recombinant LH supplementation during ovarian stimulation modulates early embryo morphokinetics without affecting IVF outcomes in normal responders: a retrospective time-lapse study.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhereas luteinizing hormone (LH) contributes to steroidogenesis and oocyte maturation, its influence on embryo developmental kinetics has not been previously investigated using time-lapse technology. The aim of this retrospective analysis was to assess embryo morphokinetics following rLH supplementation in expected normal responders undergoing ovarian stimulation and evaluate associated embryological and reproductive outcomes.
methodsA total of 120 patients were stimulated with either rFSH + rLH (n = 60) or rFSH alone (n = 60). Overall, 927 embryos were cultured in the Geri plus® time-lapse system and annotated for key morphokinetic parameters, including pronuclear dynamics, cleavage stages, morula formation, and blastocyst development. Clinical outcomes following fresh and frozen embryo transfer were also compared between groups.
resultsNo differences were observed in baseline characteristics or ovarian stimulation outcomes, including oocyte yield, fertilization rate, cleavage rate, or usable blastocyst rate. Clinical pregnancy, miscarriage, live birth, and cumulative live birth rates were comparable between the two treatment groups. Embryo morphological quality was similar in both groups. Time-lapse analysis revealed that embryos derived from rFSH + rLH cycles exhibited accelerated early developmental kinetics, characterized by earlier pronuclear appearance, pronuclear fading, and first cleavage. In contrast, subsequent cleavage timings and later-stage morphokinetic parameters were comparable between groups. No differences in morphological or morphokinetic features were observed among implanted blastocysts.
conclusionrLH supplementation during ovarian stimulation modulates specific early zygotic events without affecting later embryo development, implantation, or live birth, indicating that routine rLH addition does not alter embryo competence in expected normal responders.
Indexed as
Identifiers
42399463What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.